{"name":"TRYP Therapeutics","slug":"tryp-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNWE13UWg0d1UtcXpDY1BhTEwtNFUzU0pxWC1PcDgySUsxblBXai1aSkdrNmphaUtEQVRrVi04VzBGMUwwaG9YYVFiUGpoR0JFWTNaYldhWENyX3ZWRHJDSC1jdU5uM2FfN2Y3YkpHTVQ5VzVub2I1QUI3X3Frd3k3MndoU3k4eFIyNG5hT2JGNElYV1pMRzFyeU1kZmlhYlp0RG1IYmlIQkdmQmY4bjZ4UHkzaklVVTVETVVuZHlhQXJlUGRPWFVGeFRSa1dDVHdiOXV3cWJVenlUQWZpN3VFbk1RVXZPbFRzelNVZg?oc=5","date":"2026-04-02","type":"pipeline","source":"Barchart.com","summary":"Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPbTQ4dFNtN3ZWMHZHY1NwMmgzbVZvVzF0VElQNWVWWXVHQ1BjTXIxTmQ4VWY4RGdfVlFVYkU0LVBPbHZJQThMQmRHRGFYc19yYXZOeFJVSjh2UFNoR2hfT0tHZmZYdmdpVDJlOWtnQklZSERqdWxidWtvVjJCLWQyMVladEh4b0hsZ0lXZGRkWXFsc1FLU1hjWkdDdmx3WmNSQ0FfT1FGcmIxejI3Rnk3LWpCbm8yNS0xQmUtVFRsajhtTHdrWkZ6S3gwNTNxd1cxTkE3RWZnS2t6V3FLY2FUN2JQbGRrVWlMY1kzRkdRcUVVMms3WUhPQnhCbkwzeWxsRnFva0oyVEVjdUx6ZTAycFBQakh0dXVSRENRb2hfTjBoNEtUOTZGdGtNem5nemJBaEQ0elRhT245eG9H?oc=5","date":"2026-01-28","type":"trial","source":"globenewswire.com","summary":"Chronic and Acute Pain Clinical Trial Pipeline Analysis: - globenewswire.com","headline":"Chronic and Acute Pain Clinical Trial Pipeline Analysis:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQMXNzcC12R2ttNkctR2pqRWhrQW9jbDMtRWpoVjNTVGFsNlphNDRBRUFGZ1FaVVVBS0UybGNjYS1XOTUxRWJ3LUl3dXk0YWJKbWtHYWVnZml5RDM1QnVXYzVyX0U5N1ZHUTVxbnBCYU9hcTdKVF8wRmp4dHgzUmpQeFV2THJ0S01fXzViUFh1ZDF6U21mTDhCSXBvdXd0SU1CLVBvdUtBdFJueVVoTnN6MGdwajVGdw?oc=5","date":"2025-11-25","type":"pipeline","source":"businessweekly.co.uk","summary":"UK-Canada alliance as BioTryp Therapeutics and Intellisyn Pharma collaborate - businessweekly.co.uk","headline":"UK-Canada alliance as BioTryp Therapeutics and Intellisyn Pharma collaborate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxPdGJJUUNiSnd0OVppZUdjbXgzbzBYc2NJTDNGWTFLaE1TaDlaT0c2OTZ0MklqbHRIbUdUYU1WdE90c2t1eUhIenJOWUdiWUxoY3YycTV6VVBEMEdqWGJ5dGxyZnotN01YQXpPN1JEVHdnWDduYl9lbW1hU1lWNDgyTkphalpINjFycnR2RHQ3M2FrdU00d1p1akZUUC1oYXo0blBKS1E3LXJJZVhMSWFCYUkzU3lhV0lOalFoSGJyYjlqeURqNloxd0d1d3BPYkJ0cHFURFJHMmpZNFYxLU9yZVVnRnZaaW1PSGEtUU1VYVNBNlk?oc=5","date":"2025-06-23","type":"trial","source":"Proactive Investors","summary":"Tryp receives green light for world-first psilocin trial targeting binge eating disorder - Proactive Investors","headline":"Tryp receives green light for world-first psilocin trial targeting binge eating disorder","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9yNE56M0FwQmJqQmxna3B0eXFjM0NXTVpTalNkR1hQM0RfUXdVZWRYcmVMV3B0MVg1dmVUM1hrU3I3RWdCZFdNQVlEZVZIRFlzdU1JT2UzNmZEM2EyZkR4ZWQtZ2FsTnIyRFBJeVZLaHlKR3FjUjZj?oc=5","date":"2024-11-29","type":"trial","source":"Clinical Trials Arena","summary":"Tryptamine Therapeutics completes dosing in obesity trial of TRP-8803 - Clinical Trials Arena","headline":"Tryptamine Therapeutics completes dosing in obesity trial of TRP-8803","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQTlN4QXBxbllsbjFneUk4VUhzLWFnNnNoRWg1eVRETzZUZlFkRXdlaHc0LW1xZzhjQWJqYjBJSTY4S1VIbzRjZHhhdXRYRFc0RlN4Mm1UT1lGZDJGWjNSdFJ6WmJTb2d6Um9iVmZMa2FLS0Z5R2IzUkxKSUNxVnJ6SkZ5ME1uMkg4NVAtN0ktT282bjA?oc=5","date":"2024-05-01","type":"pipeline","source":"Yahoo Finance","summary":"Tryp Therapeutics and Exopharm Limited Announce Completion of Plan of Arrangement - Yahoo Finance","headline":"Tryp Therapeutics and Exopharm Limited Announce Completion of Plan of Arrangement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxPSVZwOWVVTDM5b0pweWpTN0lBYWxsRnJ2d2pWZVVCNXg3aXlTcW00QzI3U3N4cHlwNEhEb05xT0VYNVFLTlRPOVhmVkx1WVFRV3Vyb3Y0SmVhQTYwLXNWSTNUeVgxbndKTFdUT0ptbWVlbWx5RmlVVEFyU3Z6cEZnSlhrTjVmQ3h5amZPSllfQTJmNHFMRWJJbWVYWlUyRU10LV9WT2pjN1UzdjZkWFFkZ0lJMktpMW0tMnFsMVJScm8ya093enNlZDVNMGhoRFh3QkhYTE5vbll5a3oxUVVTS1pjbFRNbXRQVzN2c0FvZkJiY0pYMFF1cQ?oc=5","date":"2024-01-09","type":"trial","source":"Investing News Network","summary":"Tryp Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial for the Treatment of Fibromyalgia at The University of Michigan - Investing News Network","headline":"Tryp Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial for the Treatment of Fibromyalgia at The Univ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5GcUdBV2xIVWdnUjgxcFd2MTFBVDJmcXRZYW9faUx1b1JiSjNobVBPR0RiVlE3c3F2VWRTRHlaOE00aVFfUm40b1prYzRxX2ZCVkNnWm5QMk1nSmdxQXdFci12S2F4UXBsNkJ5enltRVlwLXdFc2pkR3paNVVmQQ?oc=5","date":"2023-12-11","type":"deal","source":"microdose.buzz","summary":"Tryp Therapeutics To Be Acquired by Exopharm - microdose.buzz","headline":"Tryp Therapeutics To Be Acquired by Exopharm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNbXF2YXZkUUEybmhacjFLZXVZa2F3NlRFdXZxWnNLTWFBRldhMUs2NlpsSVRLM3VwWW1SdlN5UXpLaUR5QS1ya1kxVnZ3RnI0R2Y2NDZqWGtWVTJUTEtJWjNwbWYtcXU5MjFVQ3JFZURoNXFiOGdqd0tWQmNhMi1BUE9zLUUyaFZWWTQ2WkNnMGVUNjR2bGVjc1p5R0ZDRnQzY0szRE1Sak1lZkJFQzJwNk0yNjJDOHpZY1RlSA?oc=5","date":"2021-12-02","type":"regulatory","source":"BioSpace","summary":"Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia - BioSpace","headline":"Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQLTFFc0JIY2Y0QVNvYzZuY0VmVDBYZTJyNURiY1ZfMDJoUXJpVk1NSUhZamVOVXRFa3Bzc3NKVjVLbmJwWHdXSkdSblZXd1N1ZmdyLTF1b005TFJuQmlpSTJRQmJmVkl1TXZnUkJyRmJSdmhmX1NfQkF0S2tDQnhyc09kOEdGZVZtcHM0YjRFeks3RUZNNXpyRVpad0FqcGtvZEx0SkllR1JBT2Y5czNJTTFzUXhyQQ?oc=5","date":"2021-07-21","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Why Tryp Therapeutics is exploring the use of psilocybin to treat chronic pain - drugdiscoverytrends.com","headline":"Why Tryp Therapeutics is exploring the use of psilocybin to treat chronic pain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQcng3XzFIVl84LTN3ZjQ1RDZmd3JWVmhpWXZZY2NLbzlLbUpoM0lRUm1ORmFObXgwRUNsZ3RDNlJ6MzE1cHNNTjQ5RldIdGR5YTYtRkhmcFNROE94eENOT2psSDFhVHBQV1IzZ1ZSUUxyb1NxNFQwZ0s4dkNYUEVaSWlweVVLNXF1SFppaGI1UGU0R3VQQUZVYVdaVWJOYm9G?oc=5","date":"2021-03-04","type":"pipeline","source":"TMX Newsfile","summary":"Tryp Therapeutics Announces Application to List on OTCQB - TMX Newsfile","headline":"Tryp Therapeutics Announces Application to List on OTCQB","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPQVRodExSZUh3cnFnMlRETmxUUkJSYnpGa0NYQWhLWHFxcTZvZXgxSVk0MEJMcGRIMkE1aGxzWXV4VUJpa0RBMVBtRHNQdkNuMmdfcy1aWUFfYXRua0VkVno5UWhGYnA1VzhBTEEtbHZPbXdTVHEtUmh6NkFNaEFOUGRaYkU4alBQMDRZZDU3aWpYOHZiaVpseFBBLUoyWFZ1dHpaYWNxWEtLUEgxSjcyXzZiLTVQT3lmclNEWWZTWFBFWnJ5d3JYYWhhaUw?oc=5","date":"2021-02-12","type":"deal","source":"Psychedelic Alpha","summary":"Psychedelic Bulletin: DMT for Stroke; MindMed’s Drug Discovery Partnership; Psychedelics are in Vogue - Psychedelic Alpha","headline":"Psychedelic Bulletin: DMT for Stroke; MindMed’s Drug Discovery Partnership; Psychedelics are in Vogue","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}